PD-Rx Pharmaceuticals, Inc. (PDRX)

PD-Rx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	6.17	5.4	6.83	5.47	2.9
Cash & Short-Term Investments	6.17	5.4	6.83	5.47	2.9
Cash Growth	14.11%	-20.93%	24.87%	88.38%	-15.96%
Receivables	2.09	3.18	2.38	4.46	3.89
Inventory	1.79	2.23	1.64	1.84	2.65
Other Current Assets	0.56	0.53	0.54	0.22	0.55
Total Current Assets	10.62	11.35	11.39	11.98	10
Property, Plant & Equipment	1.28	1.44	1.52	1.24	0.83
Long-Term Deferred Tax Assets	0.02	-	0.03	-	0.07
Total Assets	11.91	12.78	12.95	13.22	10.9
Accounts Payable	0.83	1.52	0.99	1.16	1.65
Accrued Expenses	0.84	0.76	0.7	0.7	0.77
Total Current Liabilities	1.67	2.28	1.7	1.86	2.42
Long-Term Deferred Tax Liabilities	-	0	-	0.01	-
Total Liabilities	1.67	2.29	1.7	1.87	2.42
Common Stock	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	1.34	1.34	1.34	1.34	1.34
Retained Earnings	9.28	9.54	10.29	10.39	7.36
Treasury Stock	-0.41	-0.41	-0.41	-0.41	-0.24
Shareholders' Equity	10.24	10.5	11.25	11.35	8.48
Total Liabilities & Equity	11.91	12.78	12.95	13.22	10.9
Net Cash (Debt)	6.17	5.4	6.83	5.47	2.9
Net Cash Growth	14.11%	-20.93%	24.87%	88.38%	15.14%
Net Cash Per Share	3.83	3.30	4.18	3.30	1.69
Filing Date Shares Outstanding	1.64	1.64	1.64	1.65	1.72
Total Common Shares Outstanding	1.64	1.64	1.64	1.65	1.72
Working Capital	8.94	9.06	9.7	10.12	7.58
Book Value Per Share	6.23	6.38	6.84	6.90	4.95
Tangible Book Value	10.24	10.5	11.25	11.35	8.48
Tangible Book Value Per Share	6.23	6.38	6.84	6.90	4.95
Land	0.16	0.16	0.16	0.16	0.16
Buildings	1.44	1.44	1.42	1.08	0.96
Machinery	1.96	2.04	2.05	1.98	1.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.